LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 190 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 0.88 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $1,336,000 | +106.5% | 9,843 | +215.0% | 0.07% | +200.0% |
| Q2 2018 | $647,000 | -12.0% | 3,125 | -56.8% | 0.02% | -23.3% |
| Q4 2016 | $735,000 | +51.2% | 7,234 | -20.8% | 0.03% | +87.5% |
| Q4 2014 | $486,000 | +50.0% | 9,130 | +32.5% | 0.02% | +60.0% |
| Q3 2014 | $324,000 | -71.0% | 6,892 | -61.6% | 0.01% | -66.7% |
| Q2 2014 | $1,118,000 | +117.9% | 17,953 | +135.6% | 0.03% | +114.3% |
| Q1 2014 | $513,000 | – | 7,620 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 2,626,160 | $138,136,000 | 24.17% |
| KNOTT DAVID M | 1,292,566 | $67,988,972,000 | 13.87% |
| GROW Partners, LLC | 200,000 | $10,520,000 | 6.41% |
| Opaleye Management Inc. | 90,000 | $4,860,000,000 | 3.82% |
| OBERWEIS ASSET MANAGEMENT INC/ | 213,317 | $11,220,000 | 2.72% |
| First Light Asset Management, LLC | 60,242 | $3,169,000 | 2.69% |
| Timpani Capital Management LLC | 98,956 | $5,205,000 | 2.59% |
| Iguana Healthcare Management, LLC | 75,000 | $3,945,000 | 2.25% |
| Eventide Asset Management | 134,400 | $7,069,000 | 2.18% |
| ASHFORD CAPITAL MANAGEMENT INC | 215,223 | $11,321,000 | 2.16% |